Skip to main content

The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Genetic testing for women diagnosed with ovarian cancer

The purpose of this Position Statement is to provide information and recommendations on genetic testing for women diagnosed with invasive epithelial ovarian cancer, based on available evidence and on consensus. The scope of this Position Statement encompasses genetic testing for heritable, or germline, gene mutations, with a focus on genetic testing of BRCA1 and BRCA2. The intended audiences are health professionals, medical colleges, consumers, media and policy makers.